Modified Liver Cells Keep Diabetes under Control

Join Our Community of Science Lovers!

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

Diabetes affects millions of Americans who must monitor their blood sugar closely for life and often undergo frequent insulin injections to avoid undue health complications. So far, cell replacement therapies to reinstate insulin-producing tissue have been limited by the availability of donor cells and the need for lifelong immunosuppression. But the results of a recent study offer new hope for novel treatment options. Scientists have successfully modified liver cells to produce insulin that, when transplanted into mice, brought the disease under control.

Sarah Ferber of the Endocrine Institute in Israel and her colleagues modified adult human liver cells (AHL) to express the pancreatic and duodenal homeobox gene 1 (PDX-1). A quarter of the AHL cells transformed in this manner produced insulin, the researchers report in a paper published online this week by the Proceedings of the National Academy of Sciences. The team then transplanted the treated cells into diabetic mice and determined that the insulin-producing AHL cells store the hormone in granules in much the same way that regular beta-cells in the pancreas do. (In the image of AHL cells above, insulin is shown in red.) Over time, insulin was secreted and subsequently controlled the glucose levels in the animals' bloodstream. Treated diabetic mice reacted to an influx of sugar in the same manner as healthy control animals, suggesting the PDX-1-treated liver cells can stand in for of beta-cells.

The success reveals a tantalizing way to avoid complications caused by transplantation of donor tissue in the future: diabetics could conceivably be the donors of their own insulin-producing tissue.�

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American